Musculoskeletal Disorders
Latest News
Mobile App Shows Promise in Managing Fibromyalgia Symptoms
“The results found in the study are essential for professionals who care for patients with fibromyalgia as they present a new viable treatment...
Latest News
Hip Fractures in Patients With Dementia: To Operate or Not?
Among patients with dementia living at home with a fracture of the head or neck of the femur, those who underwent surgery had a lower risk for...
Latest News
Type 2 Diabetes Fracture Risk Likely Due to Impaired Physical Function
Despite having higher bone mineral density, older women with type 2 diabetes have higher fracture risk and poorer physical performance than older...
From the Journals
US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives
Use of infliximab biosimilars in the United States rose slowly until three were on the market; it continued to remain lower for Medicare than for...
Latest News
Early Knee Osteoarthritis: Exercise Therapy’s Golden Window
Patients with knee osteoarthritis symptoms for less than 1 year benefit more from exercise therapy than do those with longer symptom duration.
Commentary
Chronic Neck Pain: A Primary Care Approach
There are three types but the most common and least serious is mechanical neck pain.
News from the FDA/CDC
Pyzchiva Receives FDA Approval as Third Ustekinumab Biosimilar
The biosimilar is approved for all indications of the reference medication, Stelara, and will launch in February 2025.
Conference Coverage
First-line Canakinumab Without Steroids Shows Effectiveness for Systemic Juvenile Idiopathic Arthritis
For JIA, a disease with limited options, a three-injection course of canakinumab was associated with durable control of disease in the absence of...
Latest News
Walking and Education Plan Improves Low Back Pain in Older Adults
A combination of education and a regular walking program reduced the days to recurrence of low back pain compared with no intervention.
News from the FDA/CDC
FDA Grants New Pediatric Arthritis Indications for Upadacitinib
The JAK inhibitor’s safety profile for patients as young as 2 years was similar to the known safety profile in adults.
Latest News
Over-the-Counter Arthritis Supplements Pose Adrenal Danger
Patients taking OTC arthritis supplements may need to taper use to avoid adrenal insufficiency, dysfunction, says presenter.